Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

EGX:RMDA Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49.23	64.69	52.36	66.96	14	13.23
Short-Term Investments	59.55	189.7	260.9	361.86	468.01	469.35
Cash & Short-Term Investments	108.78	254.39	313.25	428.82	482.01	482.58
Cash Growth	-68.25%	-18.79%	-26.95%	-11.04%	-0.12%	-6.99%
Accounts Receivable	694.78	791.26	353.74	276.6	265.96	238.41
Other Receivables	84.93	103.43	72.16	22.6	25.2	33.11
Receivables	1,475	1,582	1,344	923.28	684.61	666.63
Inventory	954.25	751.34	303.26	348.41	259.4	305.48
Prepaid Expenses	14.23	4.29	2.21	2.83	0.99	0.91
Other Current Assets	304.51	544.65	60.33	55.14	48.64	40.98
Total Current Assets	2,856	3,137	2,023	1,758	1,476	1,497
Property, Plant & Equipment	625.65	621.52	606.05	556.98	554.99	538.16
Other Intangible Assets	1,015	552.79	589.27	457.57	389.66	214.57
Total Assets	4,497	4,311	3,218	2,773	2,420	2,249
Accounts Payable	254.17	264.36	102.41	120.25	61.53	46.93
Accrued Expenses	87.41	115.09	76.44	62.92	37.31	21.18
Short-Term Debt	1,728	1,555	1,098	910.18	842.6	823.75
Current Portion of Long-Term Debt	-	-	-	-	21.95	58.85
Current Portion of Leases	3.4	4.48	4.81	3.66	3.13	2.6
Current Income Taxes Payable	124.2	98.78	60.59	53.71	33.49	18.31
Other Current Liabilities	66.9	117.77	30.67	31.23	22.05	18.71
Total Current Liabilities	2,264	2,155	1,373	1,182	1,022	990.33
Long-Term Debt	-	-	-	-	-	29.55
Long-Term Leases	6.77	7.19	11.7	16.34	12.26	14.81
Long-Term Deferred Tax Liabilities	68.61	77.28	58.23	51.56	40.5	31.06
Total Liabilities	2,340	2,240	1,443	1,250	1,075	1,066
Common Stock	375.87	378.23	375	250	250	192.15
Additional Paid-In Capital	303.65	327.51	377.7	397.52	486.97	486.97
Retained Earnings	1,434	1,351	1,022	921.68	610.87	505.79
Treasury Stock	-	-26.23	-26.23	-65.93	-	-
Comprehensive Income & Other	13.31	13.31	14.21	15.31	0.28	0.28
Total Common Equity	2,127	2,044	1,763	1,519	1,348	1,185
Minority Interest	31.07	27.38	12.94	4.59	-2.62	-1.62
Shareholders' Equity	2,158	2,072	1,775	1,523	1,345	1,184
Total Liabilities & Equity	4,497	4,311	3,218	2,773	2,420	2,249
Total Debt	1,738	1,566	1,114	930.18	879.94	929.56
Net Cash (Debt)	-1,630	-1,312	-801.18	-501.37	-397.93	-446.98
Net Cash Per Share	-1.08	-0.87	-0.53	-0.34	-0.26	-0.29
Filing Date Shares Outstanding	1,503	1,503	1,491	1,491	1,523	1,523
Total Common Shares Outstanding	1,503	1,503	1,491	1,478	1,523	1,523
Working Capital	591.98	981.82	650.11	576.53	453.59	506.26
Book Value Per Share	1.41	1.36	1.18	1.03	0.89	0.78
Tangible Book Value	1,111	1,491	1,173	1,061	958.45	970.62
Tangible Book Value Per Share	0.74	0.99	0.79	0.72	0.63	0.64
Land	18.64	18.64	18.64	18.64	18.64	18.64
Buildings	296.7	294.77	288.43	279.17	273.34	257.23
Machinery	656.24	646.31	585.04	533.6	491.55	462.1
Construction In Progress	37.48	33.46	38.09	12.86	27.04	26.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.